Indian firms face hike in raw material prices at home and China
This article was originally published in Scrip
Executive Summary
Indian drug manufacturers, already under pressure due to high raw material prices or scarce supplies from China, claim that domestic public sector firms have hiked prices of certain basic chemicals, substantially adding to their woes.